Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression von Yano, Masahiko, Ohkoshi, Shogo, Aoki, Yo-hei, Takahashi, Hiromichi, Kurita, Sou, Yamazaki, Kazuhide, Suzuki, Kenta, Yamagiwa, Satoshi, Sanpei, Ayumi, Fujimaki, Shun, Wakai, Toshifumi, Kudo, Shin-ei, Matsuda, Yasunobu, Aoyagi, Yutaka

Volltext

Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis C von Aoki, Yo-hei, Ohkoshi, Shogo, Yamagiwa, Satoshi, Yano, Masahiko, Takahashi, Hiromichi, Waguri, Nobuo, Igarashi, Kentaro, Sugitani, Soh-ichi, Takahashi, Toru, Ishikawa, Toru, Kamimura, Tomoteru, Wakabayashi, Hiroto, Watanabe, Toshiaki, Matsuda, Yasunobu, Nomoto, Minoru, Aoyagi, Yutaka

Volltext

Early upsurge in anti‐HBs titer possibly caused by the immunomodulative, not by the mutagenetic effect of interferon and ribavirin von Yamazaki, Kazuhide, Ohkoshi, Shogo, Maruyama, Masaki, Aoki, Yo‐hei, Yano, Masahiko, Kurita, So, Suzuki, Kenta, Matsuda, Yasunobu, Sugimura, Kazuhito, Aoyagi, Yutaka

Volltext

Very-Low-Dose Pegylated Interferon α2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention von Ohkoshi, Shogo, Yamagiwa, Satoshi, Yano, Masahiko, Takahashi, Hiromichi, Aoki, Yo-hei, Matsuda, Yasunobu, Aoyagi, Yutaka

Volltext

Progression of hypermethylation of the p16(INK4A) gene from normal liver to nontumorous liver and hepatocellular carcinoma: an evaluation using quantitative PCR analysis von Kurita, So, Ohkoshi, Shogo, Yano, Masahiko, Yamazaki, Kazuhide, Suzuki, Kenta, Aoki, Yo-hei, Matsuda, Yasunobu, Wakai, Toshifumi, Shirai, Yoshio, Ichida, Takafumi, Aoyagi, Yutaka

Volltext

Temporal treatment with interferon-β prevents hepatocellular carcinoma in hepatitis B virus X gene transgenic mice von Yamazaki, Kazuhide, Suzuki, Kenta, Ohkoshi, Shogo, Yano, Masahiko, Kurita, So, Aoki, Yo-hei, Toba, Ken, Takamura, Masa-aki, Yamagiwa, Satoshi, Matsuda, Yasunobu, Aoyagi, Yutaka

Volltext

Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B von Ohkoshi, Shogo, Yoshimura, Akira, Yamamoto, Satoshi, Yano, Masahiko, Kurita, So, Yamazaki, Kazuhide, Aoki, Yo-hei, Yamagiwa, Satoshi, Wakabayashi, Hiroto, Sugiyama, Motoya, Takahashi, Tohru, Ishikawa, Tohru, Matsuda, Yasunobu, Ichida, Takafumi, Kamimura, Tomoteru, Aoyagi, Yutaka

Volltext

Characterization of elevated alanine aminotransferase levels during pegylated-interferon alpha -2b plus ribavirin treatment for chronic hepatitis C von Aoki, Yo-hei, Ohkoshi, Shogo, Yamagiwa, Satoshi, Yano, Masahiko, Takahashi, Hiromichi, Waguri, Nobuo, Igarashi, Kentaro, Sugitani, Soh-ichi, Takahashi, Toru, Ishikawa, Toru, Kamimura, Tomoteru, Wakabayashi, Hiroto, Watanabe, Toshiaki, Matsuda, Yasunobu, Nomoto, Minoru, Aoyagi, Yutaka

Volltext

Progression of Hypermethylation of the p16INK4A Gene from Normal Liver to Nontumorous Liver and Hepatocellular Carcinoma: An Evaluation Using Quantitative PCR Analysis von Kurita, So, Ohkoshi, Shogo, Yano, Masahiko, Yamazaki, Kazuhide, Suzuki, Kenta, Aoki, Yo-hei, Matsuda, Yasunobu, Wakai, Toshifumi, Shirai, Yoshio, Ichida, Takafumi, Aoyagi, Yutaka

Volltext

Progression of Hypermethylation of the p16 INK4A Gene from Normal Liver to Nontumorous Liver and Hepatocellular Carcinoma: An Evaluation Using Quantitative PCR Analysis von Kurita, So, Ohkoshi, Shogo, Yano, Masahiko, Yamazaki, Kazuhide, Suzuki, Kenta, Aoki, Yo-hei, Matsuda, Yasunobu, Wakai, Toshifumi, Shirai, Yoshio, Ichida, Takafumi, Aoyagi, Yutaka

Volltext

Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention von Ohkoshi, Shogo, Yamagiwa, Satoshi, Yano, Masahiko, Takahashi, Hiromichi, Aoki, Yo-Hei, Matsuda, Yasunobu, Aoyagi, Yutaka

Volltext

Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention von Ohkoshi, Shogo, Yamagiwa, Satoshi, Yano, Masahiko, Takahashi, Hiromichi, Aoki, Yo-Hei, Matsuda, Yasunobu, Aoyagi, Yutaka

Volltext

Early upsurge in anti-HBs titer possibly caused by the immunomodulative, not by the mutagenetic effect of interferon and ribavirin von Yamazaki, Kazuhide, Ohkoshi, Shogo, Maruyama, Masaki, Aoki, Yo-hei, Yano, Masahiko, Kurita, So, Suzuki, Kenta, Matsuda, Yasunobu, Sugimura, Kazuhito, Aoyagi, Yutaka

Volltext